Symposium F: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation: exploiting the nano-bio interface for clinical translation (2023)
- Authors:
- USP affiliated authors: BERNARDI, JULIANA CANCINO - FFCLRP ; ZUCOLOTTO, VALTENCIR - IFSC
- Unidades: FFCLRP; IFSC
- Subjects: MEDICINA (APLICAÇÕES); NANOPARTÍCULAS; NANOTECNOLOGIA; PESQUISA CIENTÍFICA
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Pesquisa em Materiais - SBPMat
- Publisher place: Rio de Janeiro
- Date published: 2023
-
ABNT
Symposium F: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation: exploiting the nano-bio interface for clinical translation. . Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. . Acesso em: 15 maio 2024. , 2023 -
APA
Symposium F: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation: exploiting the nano-bio interface for clinical translation. (2023). Symposium F: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation: exploiting the nano-bio interface for clinical translation. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. -
NLM
Symposium F: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation: exploiting the nano-bio interface for clinical translation. 2023 ;[citado 2024 maio 15 ] -
Vancouver
Symposium F: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation: exploiting the nano-bio interface for clinical translation. 2023 ;[citado 2024 maio 15 ] - Imunossensor impedimétrico baseado em apo e holo transferrina aplicado à determinação de células cancerosas
- Symposium T: Nanomaterials in Medicine, Nanotoxicology and Nanoregulation
- Symposium C: Materials in Medicine, Nanotoxicology and Nanoregulation
- Symposium Q: Materials and Devices for Innovation in the Agribusiness
- Titanium dioxide nanoparticle (TiO2 NP) induces toxic effects on LA-9 mouse fibroblast cell line
- Symposium T: Materials and Devices for Innovation in the Agribusiness
- Cancer immunosensor based on apo and holo transferrin binding
- Pesquisadores da USP de São Carlos desenvolvem novo biossensor para SARS-CoV-2. [Depoimento a Rui Sintra]
- Theranostic nanomaterials coated with cell membrane for nanomedicine applications
- Desenvolvimento de nanocápsulas de astaxantina para aplicação como agente antioxidante em nanomedicina
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
